Axsome Therapeutics, Inc. (AXSM)
NASDAQ · Healthcare
Axsome Therapeutics, Inc. Net Income 2022–2025
Axsome Therapeutics, Inc. annual/quarterly net income history and growth rate from 2022 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Axsome Therapeutics, Inc. net income for the quarter ending March 31, 2026 was -64.5 M, a 8.63% increase year-over-year.
- Axsome Therapeutics, Inc. net income for the twelve months ending March 31, 2026 was -219.2 M, a 20.16% decrease year-over-year.
- Axsome Therapeutics, Inc. annual net income for 2025 was -183.2 M, a 36.22% decrease from 2024.
- Axsome Therapeutics, Inc. annual net income for 2024 was -287.2 M, a 20.05% increase from 2023.
- Axsome Therapeutics, Inc. annual net income for 2023 was -239.2 M, a 27.84% increase from 2022.
- Axsome Therapeutics, Inc. annual net income for 2022 was -187.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Axsome Therapeutics, Inc. Net Income — FAQ
Axsome Therapeutics, Inc. (AXSM) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Axsome Therapeutics, Inc.'s net income?
Axsome Therapeutics, Inc. (AXSM) reported net income of -$183M for fiscal 2025.
Where can I see AXSM's net income history?
The chart and table above show Axsome Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.